Ramirez, Karen Criz .

HRN: 26-99-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2025
CEFUROXIME 1.5GM (VIAL)
04/23/2025
04/24/2025
IV
1.5g
Q8
SP NSVD With RMLE
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: